DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
NCT: NCT05701917 · RECRUITING
Brief Summary
This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conservative Medical Management Arm) in the treatment of subjects with symptomatic unilateral iliofemoral DVT. The study will collect data on demographics, comorbidities, details from the DVT diagnosis and treatment, and clinical outcomes through the 6-month follow up visit.
Frequently Asked Questions
What is DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis?
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis is a clinical trial registered under NCT05701917. Current status: RECRUITING.
What is the status of NCT05701917?
The current status of NCT05701917 (DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis) is: RECRUITING.
When did DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis start?
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis started on 2023-01-06.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.